KIORA PHARMACEUTICALS, INC. (KPHMW) Total liabilities 2016–2025
KIORA PHARMACEUTICALS, INC. (KPHMW) total liabilities at each fiscal year-end, per SEC filings.
$8.1MFY2025 · since FY2016: $10.1M → $8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1M | -24.2% |
| FY2024 | $10.7M | +41.1% |
| FY2023 | $7.6M | — |
| FY2021 | $5.6M | -0.4% |
| FY2020 | $5.6M | +59.7% |
| FY2019 | $3.5M | -34.7% |
| FY2018 | $5.3M | -67.1% |
| FY2017 | $16.2M | +61.4% |
| FY2016 | $10.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Net marginKPHMW Gross profitKPHMW Gross marginKPHMW Operating incomeKPHMW Operating marginKPHMW Operating cash flowKPHMW Free cash flowKPHMW Capital expendituresKPHMW Return on equityKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Shareholders’ equityKPHMW overview →